Recombinant Saimiriine herpesvirus 2 Transforming protein STP(1), also referred to as STP-C488, is a viral oncoprotein crucial for the transforming activity of Herpesvirus saimiri (HVS) . HVS, specifically group C strains, can transform human and simian T-lymphocyte populations into permanent, antigen-independent growth . The protein is not required for viral replication, but it is essential for transformation .
Antibody Production Antibodies against STP-C488 can be produced in rabbits by immunizing them with keyhole limpet hemocyanin-conjugated synthetic peptides specific to the predicted STP-C488 sequence .
Detection Methods The STP-C488-encoded protein can be detected in various cell types, including recombinant Escherichia coli, transformed Rat-1 cells, transfected COS-1 cells, and common marmoset T lymphocytes immortalized by HVS strain 488 .
Interaction with Ras STP-C488 associates with cellular Ras proteins in transformed cells . Mutations disrupting this association impair the transforming ability of the STP-C488 oncogene . STP-C488 can compete with Raf-1 for binding to Ras, activating the Ras signaling pathway, increasing the Ras-GTP to Ras-GDP ratio, and constitutively activating mitogen-activated protein kinase (MAPK) .
Downstream Effects Expression of STP-C488 induces Ras-dependent neurite outgrowth in PC12 cells, indicating that STP-C488 can mediate oncogenic transformation by associating with cellular Ras .
STP Replacement Studies Experiments have been conducted where the STP-C488 oncogene was replaced with cellular normal Ras (c-Ras) or viral oncogenic Ras (v-Ras) in recombinant strains of HVS C488 . Recombinant HVS deltaSTP/v-Ras immortalized primary common marmoset T lymphocytes to interleukin-2-independent growth as efficiently as wild-type HVS C488, whereas recombinant HVS deltaSTP/c-Ras did so with lower efficiency .
Phenotypic Changes Cells immortalized with HVS deltaSTP/c-Ras and HVS deltaSTP/v-Ras were primarily CD4+ CD8+ double-positive T lymphocytes, unlike wild-type HVS, which immortalized CD4- CD8+ single-positive T lymphocytes . HVS deltaSTP/v-Ras-immortalized T cells showed high Ras expression and an adherent macrophage-like morphology, likely due to the activation of AP-1 transcriptional factor activity .
Tumor Induction Both HVS deltaSTP/v-Ras and HVS deltaSTP/c-Ras induced lymphoma in common marmosets, with the v-Ras virus leading to a more rapid onset of the disease .
K1 of KSHV Kaposi's sarcoma-associated herpesvirus (KSHV) contains an open reading frame called K1 at a position equivalent to the STP gene in HVS . Although KSHV and HVS are related, K1 and STP do not share amino acid sequence similarity or structural organization . K1 expression in rodent fibroblasts induces morphologic changes and focus formation, indicative of transformation. A recombinant herpesvirus in which the STP oncogene of HVS was replaced with K1 immortalized primary T lymphocytes to IL-2 independent growth and induced lymphoma in common marmosets, demonstrating the transforming potential of the K1 gene of KSHV .
Tio of Herpesvirus Ateles Herpesvirus ateles has a gene called tio located at a genomic position equivalent to the HVS oncogenes. The tio gene product, Tio, shares sequence homologies with both StpC and Tip . Studies using recombinant viruses show that Tio can replace StpC and Tip in transforming monkey and human T cells .
Growth Transformation Herpesvirus saimiri C488 can induce growth transformation of human T cells without needing further stimulation by an antigen .
IL-2 Independence Recombinant viruses expressing Tio can reduce the requirement for exogenous IL-2, typically seen with wild-type HVS C488-transformed cells, resulting in high transformation efficiency even without exogenous IL-2 .
KEGG: vg:1488260
STP (Saimiri Transformation-associated Protein) is a viral protein encoded by Herpesvirus saimiri that is not required for viral replication but is essential for in vitro immortalization of T lymphocytes and for the lymphoma-inducing capacity of the virus . It functions as a viral oncogene capable of transforming T cells through interaction with cellular signaling pathways. The protein has different variants corresponding to different viral subgroups (A, B, and C), with distinct molecular mechanisms of action but similar transforming capabilities . These variants differ in sequence but retain critical functional domains that mediate interactions with host cell proteins involved in signal transduction.
STP variants from different viral subgroups show considerable sequence divergence while maintaining key functional domains. Sequence analysis of subgroup A STP variants reveals:
A highly conserved acidic amino terminus
Extensive amino acid substitutions within the central region
A well-conserved hydrophobic carboxyl terminus
Amino acid identities varying from 73% to 99% among different subgroup A isolates
The subgroup C STP (STP-C488) differs significantly from subgroup A STPs and is co-expressed with another protein called Tip (tyrosine kinase-interacting protein) from a bicistronic mRNA . Both proteins are essential for the transforming capabilities of subgroup C viruses. While the specific structural details vary, all STP variants maintain the ability to interact with cellular signaling pathways critical for cell transformation.
STP plays a central role in the pathogenic properties of Herpesvirus saimiri. Experimental evidence clearly demonstrates this relationship:
Deletion mutants lacking STP fail to transform T lymphocytes in vitro and do not induce lymphomas in susceptible primates
Wild-type HVS produces fatal lymphoma within 19-20 days in common marmosets, while STP deletion mutants are non-oncogenic
STP is dispensable for viral replication and persistence, as virus can be repeatedly isolated from peripheral blood of marmosets infected with STP-deletion mutants
The transforming and pathogenic capabilities of Herpesvirus saimiri are directly linked to the presence of functional STP, making it a key determinant of the virus's oncogenic potential. Different viral subgroups (A, B, and C) have been established based on the pathogenic phenotypes and sequence variations in this region of the viral genome .
STP-A interacts with cellular signaling pathways primarily through its association with src family kinases. Key aspects of this interaction include:
The highly conserved YAEV/I motif at amino acid residues 115-118 is preceded by negatively charged glutamic acid residues, closely matching the consensus sequence for binding to SH2 domains of src family kinases
STP-A has been demonstrated to associate with cellular src and serves as an in vitro substrate for src kinase
Mutational analysis of STP-A11 shows that binding to src kinase requires the tyrosine residue at position 115, confirming that YAEV/I is a likely binding motif for src
Following tyrosine phosphorylation of STP-A11 by src, the protein can subsequently bind to other src family kinases including lck and fyn in vitro
These interactions suggest a model where STP-A recruitment of src family kinases leads to dysregulation of normal T-cell signaling, contributing to uncontrolled cellular proliferation and ultimately transformation.
STP-C488 from subgroup C viruses contains several functional domains that contribute to its transforming capacity:
STP-C fulfills typical criteria of an oncogene
It interacts with Ras and tumor necrosis factor-associated factors
STP-C induces mitogen-activated protein kinase activation
In subgroup C viruses, STP-C and Tip are transcribed from a single bicistronic mRNA, and both proteins are essential for transformation and leukemia induction . While STP-C mediates interactions with Ras and TNF-associated factors, its partner protein Tip interacts with:
RNA transport factor Tap
Signal transduction and activation of transcription factors
T-cellular tyrosine kinase Lck, which is activated by this interaction and phosphorylates Tip as a substrate
Together, these interactions create a network of dysregulated signaling that drives T-cell transformation.
Multiple lines of experimental evidence confirm the essential role of STP in cellular transformation:
Mutant forms of HVS with deletions in STP-C488 fail to immortalize common marmoset T lymphocytes to interleukin-2-independent growth in vitro
Wild-type HVS produces fatal lymphoma within 19-20 days following experimental infection of common marmosets, while STP deletion mutants are non-oncogenic
Both STP and Tip are required for transformation, as deletion of either protein abolishes transforming capability
Despite lacking transforming ability, STP deletion mutants maintain the ability to replicate and persist, as virus can be repeatedly isolated from the peripheral blood of marmosets infected with mutant virus for more than 5 months
These findings conclusively demonstrate that while STP is dispensable for viral replication and persistence, it is absolutely essential for the transforming phenotype both in vitro and in vivo.
Researchers typically use the following methods to express and purify recombinant STP:
Cloning and sequencing: STP genes from various subgroup isolates are cloned into appropriate expression vectors. For example, STP genes from six subgroup A isolates were cloned and sequenced to assess sequence variation effects on function .
Expression systems: Common expression systems include:
Bacterial expression (E. coli) for structural studies
Mammalian expression systems (HEK293T, COS cells) for functional studies
Baculovirus expression for higher protein yields with eukaryotic processing
Purification strategies:
Affinity chromatography using epitope tags (His, GST, FLAG)
Ion exchange chromatography
Size exclusion chromatography for final purification
Functional verification: Activity of purified protein is typically assessed through:
In vitro kinase assays with src family kinases
Binding assays with potential cellular partners
Structural analysis using circular dichroism or other methods
When designing expression constructs, it's important to consider the conserved domains identified through sequence analysis, as the acidic amino terminus and hydrophobic carboxyl terminus are well conserved and likely critical for function .
Several complementary approaches are employed to study STP interactions with cellular proteins:
Co-immunoprecipitation assays: Used to demonstrate physical association between STP and cellular kinases such as src, lck, and fyn .
In vitro kinase assays: Used to show that STP serves as a substrate for src kinase and becomes phosphorylated at specific tyrosine residues .
Mutational analysis: Site-directed mutagenesis of key residues (such as tyrosine 115 in STP-A11) to identify specific amino acids required for protein-protein interactions .
Yeast two-hybrid screening: To identify novel cellular binding partners.
Mass spectrometry-based approaches: Including immunoprecipitation followed by mass spectrometry to identify protein complexes formed with STP in cells.
Immunofluorescence microscopy: To examine co-localization of STP with cellular proteins in intact cells.
These approaches have revealed that STP-A associates with src family kinases through a conserved YAEV/I motif at amino acid residues 115-118, and this interaction is critical for its transforming function .
Researchers use the following methodological approaches to generate and characterize STP mutants:
Generation of mutants:
Site-directed mutagenesis for introducing specific point mutations (particularly in conserved motifs)
PCR-based techniques for generating deletion constructs
Recombineering or BAC mutagenesis for introducing mutations into the full viral genome
Mutant characterization:
Binding assays with purified proteins to assess interaction with cellular partners
Transformation assays in cultured cells to determine effects on transforming capacity
In vivo pathogenesis studies in animal models like common marmosets
Biochemical analysis of signaling pathway activation
Functional verification:
Comparison of wild-type virus with mutant versions for ability to transform T cells
Assessment of protein-protein interactions through co-immunoprecipitation
Analysis of downstream signaling effects
Studies using this approach have demonstrated that tyrosine 115 in STP-A11 is critical for binding to src kinase, confirming the YAEV/I motif as a likely binding site for src . Similarly, deletion mutants lacking either STP or Tip failed to transform T cells in vitro or cause lymphomas in vivo, establishing their essential role in oncogenesis .
STP-expressing Herpesvirus saimiri provides valuable tools for T-cell immunology research:
Generation of stable T-cell lines:
Preserved T-cell functionality:
Research applications:
This system offers significant advantages over standard methods for T-cell culture by allowing the establishment of stable, functional T-cell lines that maintain their specialized properties.
T cells transformed by Herpesvirus saimiri show relatively limited genetic alterations:
Viral genome persistence:
Cellular gene expression changes:
Despite retaining many normal T-cell functions, some changes in gene expression occur
A novel cellular gene, ak155, a sequence homolog of interleukin-10, is specifically overexpressed in HVS-transformed T cells
AK155 is secreted into the supernatant and forms homodimers similarly to interleukin-10
This lymphokine may contribute to the transformed phenotype
Cell signaling alterations:
These findings indicate that HVS transformation induces specific changes in cellular gene expression while preserving many aspects of normal T-cell function and phenotype.
STP's transforming mechanisms show both similarities and differences compared to other viral oncoproteins:
Unique aspects of STP transformation:
Comparison with other viral oncoproteins:
Like many viral oncoproteins, STP targets conserved signaling pathways (MAPK, NF-κB)
Unlike some viral oncoproteins that target tumor suppressors (e.g., HPV E6/E7), STP primarily activates signaling pathways
Subgroup A STPs interact with src family kinases , resembling mechanisms used by other viral oncoproteins
Functional consequences:
Understanding these unique aspects of STP-mediated transformation provides insights into both viral pathogenesis and fundamental aspects of cellular signaling that contribute to transformation.
Herpesvirus saimiri contains multiple viral homologs of cellular genes, although their relationship with STP function presents intriguing research questions:
Cellular homologs in HVS genome:
Relationship to transformation:
Research implications:
The viral homologs may complement STP function during natural infection
They may create an optimal cellular environment for STP-mediated transformation
Study of these relationships could reveal novel aspects of viral persistence and pathogenesis
This complex relationship between viral homologs of cellular genes and the transforming proteins provides a rich area for further investigation into viral evolution and oncogenic mechanisms.
Structural analysis of STP could guide inhibitor development through several approaches:
Key structural features for targeting:
Potential inhibitor strategies:
Small molecules targeting the STP-src interaction interface
Peptide-based inhibitors mimicking key binding regions
Allosteric inhibitors that alter protein conformation
Structure-guided approaches:
Determination of high-resolution structures by X-ray crystallography or cryo-EM
Molecular dynamics simulations to identify druggable pockets
Fragment-based drug discovery targeting key functional domains
Therapeutic implications:
Inhibitors could serve as research tools to further elucidate transformation mechanisms
They might provide insights for targeting similar pathways in human cancers
The specificity of STP interactions could allow selective targeting with minimal off-target effects
While primarily valuable for basic research, such studies might eventually inform approaches to targeting similar oncogenic mechanisms in human diseases.
Research on STP provides valuable insights for understanding human gamma-herpesvirus pathogenesis:
Relevance to human herpesviruses:
Comparative insights:
Both HVS and KSHV encode proteins that manipulate cellular signaling pathways
The study of STP's interaction with src kinases, Ras, and TNF-associated factors provides models for understanding similar interactions in human viruses
Mechanisms of viral persistence in the absence of disease in natural hosts may have parallels with human virus infections
Experimental advantages:
HVS provides a tractable experimental system for studying gamma-herpesvirus pathogenesis
The ability to generate STP mutants and test their effects in vitro and in vivo allows mechanistic studies difficult to perform with human viruses
T-cell transformation by HVS provides models for understanding virus-induced lymphoproliferative disorders
The knowledge gained from studying STP contributes to our broader understanding of viral oncogenesis and may inform new approaches to preventing or treating diseases caused by related human viruses.